Amygdala
Reaching the Core of Mental Health
Health Tech & Life Sciences
Non Active, Jan 2025 ceased to operate
Company Overview
Snapshot
Founded in September 2022 by Shani Sofer, Amygdala operated with 1–10 employees. The company raised $165K across one funding round from one investor. In January 2025, Amygdala ceased to operate.
Business overview
Amygdala is a Health Tech & Life Sciences company focused on revolutionizing mental health treatment through brain-computer interface technology. The company develops innovative solutions leveraging advanced deep learning algorithms to analyze brain activity, providing personalized and effective treatments for mental health conditions such as PTSD, depression, and anxiety. Amygdala operates within the Digital Healthcare sector, targeting providers in the healthcare industry.
Log in to access full profile ›Company Intelligence Q&A
- What is Amygdala's primary focus?
- Amygdala's primary focus is to revolutionize mental health treatment by leveraging cutting-edge brain-computer interface technology and advanced deep learning algorithms to provide personalized and effective treatments for conditions like PTSD, depression, and anxiety.
- When was Amygdala founded?
- Amygdala was founded in September 2022.
- Who is a co-founder of Amygdala?
- Shani Sofer is a co-founder and CBO of Amygdala.
- What is Amygdala's operational status?
- Amygdala ceased to operate in January 2025.
- What is Amygdala's product development stage?
- Amygdala's product is in the R&D stage, focusing on developing innovative solutions leveraging advanced deep learning algorithms to analyze brain activity.